What's breaking now, across thousands of outlets.
The Wegovy maker has signed a deal to license an experimental obesity pill from China’s Jiangsu Hengrui Pharmaceuticals as it seeks to regain share of the global GLP-1 market.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.
Khyber Pakhtunkhwa has reported another polio case, taking the province’s total to four this year. The latest case involves a 17-month-old girl from Domel tehsil in Bannu district.
After months of hunting for potential buyers for multiple manufacturing sites in Germany, BioNTech said it will close these facilities after being unable to lock in a deal.
Cardiovascular disease (CVD) claims 18 million lives globally each year, accounting for one in three deaths. It is estimated that one in three South Africans live with high blood pressure, yet about…
Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after…
AnaCardio has secured €62.5 million ($70.9 million) in a Series B fundraise to help prepare its chronic advanced heart failure drug for registrational development.
When Taylor Swift's private jet usage made headlines, climate-conscious fans faced a dilemma. A new study reveals how young fans use psychological defense mechanisms to justify the pop star's carbon…
